News

Related Clinical Trials

Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease
The purpose of this study is to establish safety for CEP-1347 and to determine an efficacious dose in the treatment of Parkinson's disease. ... 
A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
This Phase I study examined the safety, tolerability and possible efficacy of gene delivery of aromatic L-amino acid decarboxylase (AADC), mediated by an adeno-associated virus vector. The gene was ... 
Electronic Compliance Monitoring in Parkinson's Disease
Patients with Parkinson's Disease (PD) depend on medication for relief of motor symptoms, and for this reason are often assumed to medicate very carefully. Overall, medication adherence is very good, ... 
Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
The ultimate goal of this proposal is to reduce dyskinesia in Parkinson's Disease (PD) patients. Dyskinesias are abnormal movements, often caused by the standard treatment forPD symptoms, levodopa. ... 
Development of Cognitive Assessment Tools in Parkinson Disease
The main objectives of this protocol are as follows: 1. To assess the sensitivity and specificity of ANAM-PD in detecting cognitive status in patients with Parkinson disease (PD) ... 
Medication Review in Patients on Anti-Parkinson Therapy
To identify patients within the community taking anti-parkinson medications in whom the diagnosis of Parkinson’s disease is incorrect and to supervise and clinically monitor the withdrawal of ... 
European Compliance Study in Parkinson's Disease
In both symptomatic and asymptomatic disease, only about half of medicines are taken as prescribed1. Relatively little is known about how patients with Parkinson’s disease take their ... 
Integrated Multidisciplinary Care for Parkinson's Disease: a Cluster Controlled Trial
The aim of the present study is to evaluate the (cost) effectiveness of a new health care system in which an individualised multidisciplinary assessment is given to patients with Parkinson's ... 
Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
Apathy usually refers to a set of behavioural, emotional and cognitive features as a reduced interest and participation in main activities of daily life, a lack of initiative, a trend ... 
Non-Interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's Disease
To assess the predictive value of sequential administration of WHO-5 and MDI (Major Depression Inventory) for the clinical management of Parkinson Disease (PD) patients by - ...